IGF-1 receptor inhibition by picropodophyllin in medulloblastoma

Biochemical and Biophysical Research Communications

Volumn 399, Issue 4, 2010, Pages 727-732

  Ohshima Hosoyama, Sachiko ^a   Hosoyama, Tohru ^a   Nelon, Laura D ^a   Keller, Charles ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b University of Texas Health Science Center   (United States)

Author keywords

Apoptosis; Insulin like growth factor 1 receptor; Medulloblastoma; Picropodophyllin; Tumor growth

Indexed keywords

PICROPODOPHYLLIN; PODOPHYLLIN; PROTEIN P53; PROTEIN PATCHED 1; SOMATOMEDIN C RECEPTOR; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR PAX7; UNCLASSIFIED DRUG; CASPASE 3; PODOPHYLLOTOXIN;

ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL DEATH; CONTROLLED STUDY; GENETIC ENGINEERING; HYPOTHESIS; IN VITRO STUDY; MEDULLOBLASTOMA; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL PROLIFERATION; CEREBELLAR NEOPLASMS; DISEASE MODEL; DRUG EFFECTS; GENE SILENCING; GENETICS; HUMAN; METABOLISM; PATHOLOGY;

ANIMALS; CASPASE 3; CELL PROLIFERATION; CEREBELLAR NEOPLASMS; DISEASE MODELS, ANIMAL; GENE KNOCKDOWN TECHNIQUES; HUMANS; MEDULLOBLASTOMA; MICE; PODOPHYLLOTOXIN; RECEPTOR, IGF TYPE 1;

MURINAE;

EID: 77956265929     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.08.009     Document Type: Article

References (26)

1. Crawford J.R., MacDonald T.J., Packer R.J. Medulloblastoma in childhood: new biological advances. Lancet Neurol. 2007, 6:1073-1085.
2. Dahmane N., Ruiz i Altaba A. Sonic hedgehog regulates the growth and patterning of the cerebellum. Development 1999, 126:3089-3100.
3. D'Mello S.R., Galli C., Ciotti T., et al. Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. Proc. Natl. Acad. Sci. USA 1993, 90:10989-10993.
4. de Pablo F., de la Rosa E.J. The developing CNS: a scenario for the action of proinsulin, insulin and insulin-like growth factors. Trends Neurosci. 1995, 18:143-150.
5. Baserga R. The insulin-like growth factor I receptor: a key to tumor growth?. Cancer Res. 1995, 55:249-252.
6. Wang J.Y., Del Valle L., Gordon J., et al. Activation of the IGF-IR system contributes to malignant growth of human and mouse medulloblastomas. Oncogene 2001, 20:3857-3868.
7. Wang Y., Hailey J., Williams D., et al. Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti-IGF-IR antibody. Mol. Cancer Ther. 2005, 4:1214-1221.
8. Urbanska K., Trojanek J., Del Valle L., et al. Inhibition of IGF-I receptor in anchorage-independence attenuates GSK-3beta constitutive phosphorylation and compromises growth and survival of medulloblastoma cell lines. Oncogene 2007, 26:2308-2317.
9. Girnita A., Girnita L., del Prete F., et al. Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth. Cancer Res. 2004, 64:236-242.
10. Vasilcanu D., Girnita A., Girnita L., et al. The cyclolignan PPP induces activation loop-specific inhibition of tyrosine phosphorylation of the insulin-like growth factor-1 receptor. Link to the phosphatidyl inositol-3 kinase/Akt apoptotic pathway. Oncogene 2004, 23:7854-7862.
11. Yin S., Girnita A., Stromberg T., et al. Targeting the insulin-like growth factor-1 receptor by picropodophyllin as a treatment option for glioblastoma. Neuro. Oncol. 2010, 12:19-27.
12. Taniguchi E., Cho M.J., Arenkiel B.R., et al. Bortezomib reverses a post-translational mechanism of tumorigenesis for patched1 haploinsufficiency in medulloblastoma. Pediatr. Blood Cancer 2009, 53:136-144.
13. Uziel T., Zindy F., Xie S., et al. The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation. Genes Dev. 2005, 19:2656-2667.
14. + progenitor gives rise to pituitary adenomas. Genes Cancer 2010, 1:388-402.
15. Corcoran R.B., Bachar Raveh T., Barakat M.T., et al. Insulin-like growth factor 2 is required for progression to advanced medulloblastoma in patched1 heterozygous mice. Cancer Res. 2008, 68:8788-8795.
16. Hartmann W., Koch A., Brune H., et al. Insulin-like growth factor II is involved in the proliferation control of medulloblastoma and its cerebellar precursor cells. Am. J. Pathol. 2005, 166:1153-1162.
17. Del Valle L., Enam S., Lassak A., et al. Insulin-like growth factor I receptor activity in human medulloblastomas. Clin. Cancer Res. 2002, 8:1822-1830.
18. Tanori M., Santone M., Mancuso M., et al. Developmental and oncogenic effects of insulin-like growth factor-I in Ptc1+/- mouse cerebellum. Mol. Cancer 2010, 9:53.
19. Sun Q., Wei X., Feng J., et al. Involvement of insulin-like growth factor-insulin receptor signal pathway in the transgenic mouse model of medulloblastoma. Cancer Sci. 2008, 99:234-240.
20. Rao G., Pedone C.A., Del Valle L., et al. Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice. Oncogene 2004, 23:6156-6162.
21. Browd S.R., Kenney A.M., Gottfried O.N., et al. N-myc can substitute for insulin-like growth factor signaling in a mouse model of sonic hedgehog-induced medulloblastoma. Cancer Res. 2006, 66:2666-2672.
22. Urbanska K., Pannizzo P., Grabacka M., et al. Activation of PPARalpha inhibits IGF-I-mediated growth and survival responses in medulloblastoma cell lines. Int. J. Cancer 2008, 123:1015-1024.
23. Vasilcanu R., Vasilcanu D., Rosengren L., et al. Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor: potential mechanistic involvement of Mdm2 and beta-arrestin1. Oncogene 2008, 27:1629-1638.
24. Stromberg T., Ekman S., Girnita L., et al. IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/M-phase accumulation and apoptosis in multiple myeloma cells. Blood 2006, 107:669-678.
25. Yang W.L., Wang J., Chan C.H., et al. The E3 ligase TRAF6 regulates Akt ubiquitination and activation. Science 2009, 325:1134-1138.
26. Carpten J.D., Faber A.L., Horn C., et al. A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature 2007, 448:439-444.